OR1L6

Across TCGA pan-cancer cohorts, OR1L6 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR1L6’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where OR1L6 RNA is repressed in tumor relative to normal tissue. In most cancer types OR1L6 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD are the cancer types where OR1L6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR1L6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	−0.034	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

OR1L6–STAD

Open the STAD breakdown →